SITPIN DM 10/500/100
SITPIN DM 10/500/100 contains Dapagliflozin 10 mg + Metformin Hydrochloride 500 mg (ER) + Sitagliptin 100 mg, a triple-action combination for comprehensive type 2 diabetes control. Dapagliflozin removes excess glucose through urine, Metformin improves insulin sensitivity and reduces liver glucose production, while Sitagliptin enhances insulin release after meals. This advanced formula helps maintain stable blood sugar levels and supports stronger long-term glycemic management.
Related products
SITAMATA 50- 1000
SITAMATA 50-1000 contains Sitagliptin 50 mg + Metformin Hydrochloride 1000 mg, a strong dual-action combination...
LINANTA M 1000
LINANTA M 1000 contains Linagliptin 2.5 mg + Metformin Hydrochloride 1000 mg, a powerful combination...
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
GLIPDIP M FORTE
GLIPDIP M FORTE is a combination therapy designed for better control of type 2 diabetes...
GLIPDIP
GLIPDIP is used for the management of type 2 diabetes mellitus. Each tablet contains Teneligliptin...
GLIBEN PM TAB
GLIBEN PM Tablet is a triple combination therapy used for effective management of type 2...
CARBOSTOP 25
CARBOSTOP 25 Tablet is a combination medicine used to manage type 2 diabetes. It contains...
